Results 121 to 130 of about 98,508 (216)

Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers. [PDF]

, 2019
BACKGROUND: Ticagrelor is an oral P2Y12 inhibitor that is used with aspirin to reduce the risk of ischemic events among patients with acute coronary syndromes or previous myocardial infarction.
Arnold, Susan E., Bhatt, Deepak L., Jennings, Lisa K., Lee, John S., Mays, Michael C., Pollack, Charles V., Umstead, Bret R., Weitz, Jeffrey I., Xu, Sherry   +8 more
core   +1 more source

Synthesis of potent vasodilating agents: in silico and in vitro evaluation of 6-(4-substitutedphenyl)-3-pyridazinone derivatives as potential hydralazine analogues

Scientific Reports
People of all age categories and lifestyles suffer to different extents from hypertension. Accordingly, this necessitates the rise of new ways to defeat this enemy.
Marian W. Aziz, Khaled O. Mohamed, Doaa B. Farag, Amira Karam Khalifa, Zeinab Mahmoud   +4 more
doaj   +1 more source

Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients

International Journal of COPD, 2017
Mariana Muñoz-Esquerre,1 José Luis Ferreiro,2 Daniel Huertas,1,3 Ana Lucrecia Marcano,2 Marta López-Sánchez,1 Gerard Roura,2 Joan Antoni Gómez-Hospital,2 Jordi Dorca,1 Angel Cequier,2 Salud Santos1,3 1Department of ...
Muñoz-Esquerre M, Ferreiro JL, Huertas D, Marcano AL, López-Sánchez M, Roura G, Gómez-Hospital JA, Dorca J, Cequier A, Santos S   +9 more
doaj  

Vasodilator β-blockers: A Different Class of Antihypertensive agents? [PDF]

, 2014
Manolis S. Kallistratos, Leonidas Poulimenos, Athanasios Manolis   +2 more
openalex   +1 more source

Polyvinylpyrrolidone-coated gold nanoparticles inhibit endothelial cell viability, proliferation, and ERK1/2 phosphorylation and reduce the magnitude of endothelial-independent dilator responses in isolated aortic vessels

International Journal of Nanomedicine, 2017
Teba Mohamed,1,* Sabine Matou-Nasri,2,* Asima Farooq,3 Debra Whitehead,3 May Azzawi1 1School of Healthcare Science, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK; 2Cell and Gene Therapy Group, Medical Genomics ...
Mohamed T, Matou-Nasri S, Farooq A, Whitehead D, Azzawi M   +4 more
doaj  

-153-THE MYOCARDIAL FUNCTION UNDER THE REPERFUSED MYOCARDIUM : THE EFFECTS OF VASODILATOR AND INOTROPIC AGENT

, 1986
Takashi Saito, Mamoru Miura, Yoshikazu Tamura, Yuichi Chiba, Nobuo Yuasa, Kouichi Yoshida, Hitoshi Matsuoka, Takehiko Tajika, Shinitsu Sato, Toyohiko Abe, Tadaya Sato, Yoshihisa Abe, Yoshiaki Kaga, Yasushi Suzuki, Shigeaki Ikeda, Tomohiro Kanazawa   +15 more
openalex   +2 more sources

Agents with vasodilator properties in acute heart failure: how to design successful trials [PDF]

, 2015
Alexandre Mebazaa, Dan Longrois, Marco Metra, Christian Mueller, Mark Richards, Lothar Roessig, Marie France Séronde, Naoki Sato, Norman Stockbridge, Wendy Gattis Stough, Ángeles Alonso, Robert Cody, Nancy Cook Bruns, Mihai Gheorghiade, Johannes Holzmeister, Sai͏̈d Laribi, Faı̈ez Zannad   +16 more
openalex   +1 more source

Modification by vasodilator agents of reoxygention- and calcium- induced contractions in isolated dog cerebral arteries.

, 1989
Ka Bian, Masahisa Kawakami, Kazuhide Ayajiki, Noboru Toda   +3 more
openalex   +1 more source

Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome [PDF]

, 2018
Julia Schümann, Eva C Henrich, Hellen Strobl, Roland Prondzinsky, Sophie Weiche, Hölger Thiele, Karl Werdan, Stefan Frantz, Susanne Unverzagt   +8 more
openalex   +1 more source

Cardiovascular Effects of NSP-804 and NSP-805, Novel Cardiotonic Agents with Vasodilator Properties

, 1993
Nobuo Mochizuki, Seiichi Uchida, Hiroo Miyata   +2 more
openalex   +1 more source